Vaso Corp. engages in the healthcare equipment and information technology industries. It operates through the following segments: Information Technology (IT), Professional Sales Service, and Equipment. The IT segment focuses on healthcare IT and managed network technology services. The Professional Sales Service segment involves in selling healthcare capital equipment. The Equipment segment comprises of designing, manufacturing, selling, and servicing proprietary medical devices. The company was founded by John C. K. Hui and William Cross in July 1987 and is headquartered in Plainview, NY.
Company profile
Ticker
VASO
Exchange
Website
CEO
Jun Ma
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • GigCapital5 • Outset Medical ...
Former names
VASOMEDICAL INC, VASOMEDICAL, INC
SEC CIK
Corporate docs
Subsidiaries
Vaso Diagnostics, Inc. • VasoMedical, Inc. • Vasomedical Global Corp. • Vasomedical Solutions, Inc. • VasoHealthcare IT Corp. • VasoTechnology, Inc. • NetWolves Network Services LLC • EECP Global Corporation • Fast Growth Enterprises Limited ...
IRS number
112871434
VASO stock data
Latest filings (excl ownership)
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Departure of Directors or Certain Officers
3 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
DEF 14A
Definitive proxy
3 Oct 22
8-K
Changes in Registrant's Certifying Accountant
16 Sep 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 9.67 mm | 9.67 mm | 9.67 mm | 9.67 mm | 9.67 mm | 9.67 mm |
| Cash burn (monthly) | 718.67 k | (no burn) | (no burn) | (no burn) | 647.00 k | (no burn) |
| Cash used (since last report) | 1.50 mm | n/a | n/a | n/a | 1.35 mm | n/a |
| Cash remaining | 8.17 mm | n/a | n/a | n/a | 8.32 mm | n/a |
| Runway (months of cash) | 11.4 | n/a | n/a | n/a | 12.9 | n/a |
Institutional ownership, Q2 2022
0.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 1 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 45.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Captrust Financial Advisors | 45.00 | $0.00 |